… of COVID-19 pandemic on nurses: experiences and tips CAR-T Cell and COVID-19 and how and when to restart the … patients with focus on stem cell transplantation and CAR-T cells (EBMT/ASTCT) Strategies to prevent and handle …

… maturation antigen-directed chimeric antigen receptor (CAR) T-cell therapy, allowed deep and durable responses in … of ide-cel resistance. Besides, other BCMA-directed CAR-T products, such as ciltacabtagene autoleucel, have …

… cured) with an autologous transplant. The introduction of CAR-T can further muddle the waters in the future. At the moment, … to support a better cure rate for patients with FL with CAR-T than with autologous transplant, contrasting with the …

… allogeneic and autologous transplantations, as well as CAR-T cell therapy. I am honoured to work alongside other …

… the Implementation and Operational Management of Marketed CAR-T Cell Therapy – submitted for publication. …

… curative, and novel disease modifying therapies, such as CAR-T cells. Christian Hedrich from University of Liverpool opens … may increase the risk of graft failure and GVHD, while CAR-T cells might offer a cure without immunological …

… reached a historic milestone— recording data for 10,000 CAR-T therapy patients . This achievement highlights the expanding role and impact of CAR-T therapy in treating haematological malignancies and …

… are over 815,900 patients, 932,900 transplants, 18,500 CAR-T treatments, 8,500 Immunosuppressive Treatments and 80 Gene …

… the field. A major such new development is the arrival of CAR-T cells, which may turn in a true revolution for the … is making efforts to deliver a roadmap to implement CAR-T programs that overcome potential limitations, secure …

… on all cases involved in the treatment of patients using a CAR-T product whether commercial or investigational.  The 1 st … to welcoming more countries in 2021 as the number of CAR-T products on the market steadily increase.   …